
- /
- Supported exchanges
- / US
- / STAA.NASDAQ
STAAR Surgical Company (STAA NASDAQ) stock market data APIs
STAAR Surgical Company Financial Data Overview
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with STAAR Surgical Company (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get STAAR Surgical Company data using free add-ons & libraries
Get STAAR Surgical Company Fundamental Data
STAAR Surgical Company Fundamental data includes:
- Net Revenue: 224 M
- EBITDA: -72 989 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-06
- EPS/Forecast: -0.56
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
STAAR Surgical Company News

Staar Surgical issues letter to stockholders regarding Alcon merger
In conjunction with the definitive proxy filing, Staar (STAA) is mailing the following letter to Staar stockholders: “On August 5, 2025, we announced that STAAR Surgical Company entered into a defin...


Is STAAR Surgical Poised for a Turnaround After Mixed Earnings in 2025?
Thinking about what to do with STAAR Surgical stock right now? You are not alone. With medical technology evolving and investor attention shifting, this eye-care innovator is on the watchlist of many ...

STAAR Surgical Board of Directors Unanimously Believes Alcon Merger Maximizes Value for STAAR Stockholders
Provides Greater Value than STAAR Could Achieve on a Standalone Basis in the Foreseeable Future and is the Best Path Forward for STAAR Stockholders Files Definitive Proxy Materials and Mails Letter t...

Broadwood files preliminary proxy to block STAAR Surgical sale; company responds
Investing.com -- STAAR Surgical Company’s (NASDAQ:STAA) contested sale to Alcon AG (NYSE:ALC) has escalated after its largest shareholder took the first formal step toward a proxy fight to defeat th...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.